| 1 |
Kotova MM, Galstyan DS, Kolesnikova TO, de Abreu MS, Amstislavskaya TG, Strekalova T, Petersen EV, Yenkoyan KB, Demin KA, Kalueff AV. Understanding CNS Effects of Antimicrobial Drugs Using Zebrafish Models. Vet Sci 2023;10. [PMID: 36851400 DOI: 10.3390/vetsci10020096] [Reference Citation Analysis]
|
| 2 |
He L, Yang BZ, Ma YJ, Wen L, Liu F, Zhang XJ, Liu TQ. Differences in clinical features and gut microbiota between individuals with methamphetamine casual use and methamphetamine use disorder. Front Cell Infect Microbiol 2023;13:1103919. [PMID: 36909722 DOI: 10.3389/fcimb.2023.1103919] [Reference Citation Analysis]
|
| 3 |
Hong H, Lu X, Lu Q, Huang C, Cui Z. Potential therapeutic effects and pharmacological evidence of sinomenine in central nervous system disorders. Front Pharmacol 2022;13:1015035. [DOI: 10.3389/fphar.2022.1015035] [Reference Citation Analysis]
|
| 4 |
Bodnar RJ. Endogenous opiates and behavior: 2020. Peptides 2022. [DOI: 10.1016/j.peptides.2022.170752] [Reference Citation Analysis]
|
| 5 |
Zhang J, Wei B, Wen R, Liu Y, Wang Z. Genetically Modified Sugarcane Intercropping Soybean Impact on Rhizosphere Bacterial Communities and Co-occurrence Patterns. Front Microbiol 2021;12:742341. [PMID: 34970232 DOI: 10.3389/fmicb.2021.742341] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 6 |
Li J, Su S, Xu Z, Zhao L, Fan R, Guo J, Qian D, Duan J. Potential roles of gut microbiota and microbial metabolites in chronic inflammatory pain and the mechanisms of therapy drugs. Therapeutic Advances in Chronic Disease 2022;13:204062232210911. [DOI: 10.1177/20406223221091177] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 7 |
Xie J, Li M, Ye W, Shan J, Zhao X, Duan Y, Liu Y, Unger BH, Cheng Y, Zhang W, Wu N, Xia XQ. Sinomenine Hydrochloride Ameliorates Fish Foodborne Enteritis via α7nAchR-Mediated Anti-Inflammatory Effect Whilst Altering Microbiota Composition. Front Immunol 2021;12:766845. [PMID: 34887862 DOI: 10.3389/fimmu.2021.766845] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 8 |
Cornuault JK, Byatt G, Paquet ME, De Koninck P, Moineau S. Zebrafish: a big fish in the study of the gut microbiota. Curr Opin Biotechnol 2021;73:308-13. [PMID: 34653834 DOI: 10.1016/j.copbio.2021.09.007] [Reference Citation Analysis]
|
| 9 |
Yadav J, El Hassani M, Sodhi J, Lauschke VM, Hartman JH, Russell LE. Recent developments in in vitro and in vivo models for improved translation of preclinical pharmacokinetics and pharmacodynamics data. Drug Metab Rev 2021;53:207-33. [PMID: 33989099 DOI: 10.1080/03602532.2021.1922435] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Lucerne KE, Osman A, Meckel KR, Kiraly DD. Contributions of neuroimmune and gut-brain signaling to vulnerability of developing substance use disorders. Neuropharmacology 2021;192:108598. [PMID: 33965398 DOI: 10.1016/j.neuropharm.2021.108598] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
|
